↓ Skip to main content

Cochrane Database of Systematic Reviews

Anti‐interleukin‐13 and anti‐interleukin‐4 agents versus placebo, anti‐interleukin‐5 or anti‐immunoglobulin‐E agents, for people with asthma

Overview of attention for article published in Cochrane database of systematic reviews, October 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

blogs
1 blog
policy
1 policy source
twitter
9 X users
facebook
2 Facebook pages

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
116 Mendeley
Title
Anti‐interleukin‐13 and anti‐interleukin‐4 agents versus placebo, anti‐interleukin‐5 or anti‐immunoglobulin‐E agents, for people with asthma
Published in
Cochrane database of systematic reviews, October 2021
DOI 10.1002/14651858.cd012929.pub2
Pubmed ID
Authors

Andrew Gallagher, Michaela Edwards, Parameswaran Nair, Stewart Drew, Aashish Vyas, Rashmi Sharma, Paul A Marsden, Ran Wang, David Jw Evans

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 116 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 116 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 11 9%
Student > Bachelor 9 8%
Researcher 8 7%
Other 7 6%
Professor 4 3%
Other 14 12%
Unknown 63 54%
Readers by discipline Count As %
Medicine and Dentistry 23 20%
Pharmacology, Toxicology and Pharmaceutical Science 7 6%
Nursing and Health Professions 7 6%
Biochemistry, Genetics and Molecular Biology 3 3%
Unspecified 2 2%
Other 7 6%
Unknown 67 58%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 April 2023.
All research outputs
#2,323,103
of 25,595,500 outputs
Outputs from Cochrane database of systematic reviews
#4,831
of 13,156 outputs
Outputs of similar age
#52,392
of 442,581 outputs
Outputs of similar age from Cochrane database of systematic reviews
#86
of 159 outputs
Altmetric has tracked 25,595,500 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,156 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 442,581 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 159 others from the same source and published within six weeks on either side of this one. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.